Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Infect Agent Cancer ; 11: 61, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27980608

RESUMO

BACKGROUND: Little is known about the epidemiological characteristics of papillomavirus (HPV) infection among North African countries. Herein, we conducted a molecular epidemiological study to investigate prevalence of HPV type and HPV-16 variants among cervical-screened unvaccinated Tunisian women. METHODS: Cross-sectional study was performed on 494 Tunisian women visiting Women's Healthcare Centers. HPV-DNA detection was carried out on cervical samples using real-time polymerase chain reaction. HPV genotyping and HPV-16 variants were characterized by direct sequencing of L1 viral capsid gene. RESULTS: The overall HPV prevalence was 34% (95% CI: 30-38%) with significantly higher prevalence among women with squamous intraepithelial lesions (SIL) than those with no intraepithelial lesions (NIL) 84% (95% CI: 76-92%) and 24.5% (95% CI: 20-29%) respectively. The distribution of HPV prevalence according to women's age shows a U-shaped curve and the highest HPV prevalence rates were observed among the youngest (≤25 years; 51.2%, 95% CI: 37-67%) and the oldest women (>55 years; 41.7%, 95% The HPV-16 prevalence was 32.8% (95% CI: 22-45%) among women with SIL and 9.2% (95% CI: 6-12%) among women with NIL. Whereas, the HPV-18 prevalence was 1.3% (95% CI: 0-5%) among women with SIL and 0.3% (95% CI: 0-1%) among women with NIL. Among HPV-16 positive women, European lineage (E) was identified as the predominant HPV-16 variant (85.7%, 95% CI: 76-95%). The frequency of E variant was lower among SIL than among NIL women (81%, 95% CI: 64-99%, and 88%, 95% CI: 77-100%, respectively). Conversely, the African-2 variant frequency was higher among SIL than among NIL women (18%, 95% CI: 1-36% and 6%, 95% CI: 2-14%, respectively). In multivariate analysis, young age was the only risk factor that is independently associated with HPV infection. Moreover, HPV infection and menopause were both found to be independently associated with SIL and HSIL. CONCLUSION: HPV DNA testing should be proposed to young and menopausal Tunisian women. Considering HPV prevalence, only 13% of the Tunisian women could be protected by the bivalent HPV vaccine. These results may be helpful for designing an adapted HPV testing and vaccination program in Tunisia.

2.
Ann Endocrinol (Paris) ; 69(3): 218-26, 2008 Jun.
Artigo em Francês | MEDLINE | ID: mdl-18462702

RESUMO

INTRODUCTION: Complete androgen insensitivity is a rare syndrome. It is caused by a mutation in the androgen receptor gene. We describe a novel mutation in exon 1. MATERIALS AND METHODS: We report the case of a 29 year-old girl with complete androgen insensitivity syndrome discovered during the exploration of a primary amenorrhoea. The family investigation revealed two other cases. RESULTS: The diagnosis was oriented by the clinical and the biological features and confirmed by the molecular study. A new mutation of the androgen receptor gene, as a deletion in exon 1 not described previously, was identified. CONCLUSION: Through these cases, clinical, hormonal and histological particularities were analysed.


Assuntos
Síndrome de Resistência a Andrógenos/genética , Mutação , Receptores Androgênicos/genética , Adolescente , Adulto , Éxons , Feminino , Humanos , Cariotipagem , Masculino , Linhagem , Deleção de Sequência , Testículo/patologia , Tunísia
3.
J Gynecol Obstet Biol Reprod (Paris) ; 36(5): 473-8, 2007 Sep.
Artigo em Francês | MEDLINE | ID: mdl-17446009

RESUMO

OBJECTIVE: To evaluate maternal trace elements and vitamins food intake in the last month of pregnancy and assess their effect on fetal weight. MATERIAL AND METHODS: It is a food intake survey led near 350 pregnant women. All women participated in a nutritional survey and were at term. To examine dietary intakes, food frequency questionnaires were completed before delivery on the diet during the last 24 hours. Authors compared the maternal intakes to the recommended allowance and analyzed the correlation between these intakes and fetal weight. RESULTS: This study confirmed the influence of factors such as parity, maternal BMI and term of pregnancy on the fetal weight. The mean daily intakes of iron (10.7 mg/day), calcium (553 mg/day), zinc (6.2 mg/day), magnesium (284.3 mg/day) were lower than recommended. The mean daily intakes of vitamins C and E did not differ from recommended allowance. Only calcium intakes were significantly correlated to birth weight. CONCLUSION: We noted a deficiency of most of these intakes compared to the recommended dietary allowance. Trace elements and vitamins C, E maternal-food intakes in the end of pregnancy don't seem to be a significant determinant of foetal weight.


Assuntos
Desenvolvimento Fetal/fisiologia , Fenômenos Fisiológicos da Nutrição Materna/fisiologia , Necessidades Nutricionais , Oligoelementos/administração & dosagem , Vitaminas/administração & dosagem , Adolescente , Adulto , Peso ao Nascer , Índice de Massa Corporal , Inquéritos sobre Dietas , Feminino , Desenvolvimento Fetal/efeitos dos fármacos , Humanos , Pessoa de Meia-Idade , Política Nutricional , Paridade , Gravidez , Resultado da Gravidez , Terceiro Trimestre da Gravidez , Inquéritos e Questionários , Oligoelementos/deficiência
4.
J Gynecol Obstet Biol Reprod (Paris) ; 36(7): 642-52, 2007 Nov.
Artigo em Francês | MEDLINE | ID: mdl-17321695

RESUMO

Premenstrual syndrome (PMS) is a recurrent disorder that occurs in the luteal phase of the menstrual cycle. It is characterized by intense physical, psychological, and behavioral changes that interrupt interpersonal relationships and disrupt the lives of affected women. Premenstrual syndrome is believed to affect 75% of women of childbearing age. Because no tests can confirm PMS, the diagnosis should be made on the basis of a patient-completed daily symptom calendar and the exclusion of other medical disorders. PMS symptoms occur during the luteal phase of the menstrual cycle and remit with the onset of menstruation or shortly afterward. The aetiology of PMS is still unknown uncertain, but are likely associated with aberrant responses to normal hormonal fluctuations during the menstrual cycle. A wide range of therapeutic interventions has been tested in the treatment of premenstrual symptoms. Most non-pharmacological interventions that have been proven efficacious require a series of interventions. If non-medical approaches are ineffective, drug therapy may be appropriate. Several pharmaceutics agents have been shown to relieve symptoms. Calcium carbonate and selective serotonin reuptake inhibitors have demonstrated excellent efficacy.


Assuntos
Síndrome Pré-Menstrual/diagnóstico , Síndrome Pré-Menstrual/terapia , Terapias Complementares , Dieta , Exercício Físico , Feminino , Humanos , Síndrome Pré-Menstrual/etiologia , Síndrome Pré-Menstrual/psicologia , Psicoterapia , Fatores de Risco , Sono
5.
Ann Fr Anesth Reanim ; 22(10): 865-9, 2003 Dec.
Artigo em Francês | MEDLINE | ID: mdl-14644368

RESUMO

OBJECTIVE: Our purpose was to characterize the risk factors of eclampsia in women with preeclampsia. PATIENTS AND METHODS: A case-control study was conducted at Monastir hospital to investigate risk factors for eclampsia between 1st January 1995 and 30th June 2000. Cases were matched to preeclamptic controls on a 2:1 ratio. Univariate analysis was used to determine which of the independent variables were significantly different between the groups. Those with significant differences were then entered into multiple logistic regression analysis to determine the characteristics that were independently related to eclampsia. RESULT: A total of 41 cases of eclampsia were ascertained from deliveries. The ratio of eclampsia cases to number of deliveries over the study period was 1.87 per 1000. The first seizures occurred at home in 59% of the cases. Univariate analysis revealed statistical significance for the following variables associated with eclampsia: systolic hypertension > or =160 mmHg and diastolic > or =110 mmHg, headache, visual symptoms, vivid deep tendon reflexes, proteinuria >3+ or >3 g d(-1), uric acid concentration > or =350 micromol l(-1), serum creatinine concentration >100 micromol l(-1) and aminotransferase aspartate >30 IU l(-1). A history of abortion appears to be the protective factor against eclampsia. However, with subsequent multivariate analysis, only vivid deep tendon reflexes and elevated uric acid concentration remained significant. CONCLUSION: These data indicate a need for improved prenatal care and medical attention focused on prodroms of eclampsia as well as the detection of preeclampsia to reduce the incidence of eclampsia.


Assuntos
Eclampsia/epidemiologia , Adulto , Análise de Variância , Aspartato Aminotransferases/sangue , Estudos de Casos e Controles , Creatinina/urina , Feminino , Cefaleia/etiologia , Cefaleia/fisiopatologia , Humanos , Hipertensão/etiologia , Hipertensão/fisiopatologia , Recém-Nascido , Modelos Logísticos , Pré-Eclâmpsia/epidemiologia , Pré-Eclâmpsia/fisiopatologia , Gravidez , Proteinúria , Reflexo de Estiramento/fisiologia , Fatores de Risco , Convulsões/fisiopatologia , Ácido Úrico/sangue , Transtornos da Visão/etiologia , Transtornos da Visão/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...